TRIMAS REPORTS THIRD QUARTER 2026 RESULTS
TRIMAS CORP (TRS) filed an SEC Form 8-K — Results of Operations and Financial Condition. TRIMAS REPORTS THIRD QUARTER 2026 RESULTS • Third quarter net sales increased 7.7% year-over-year, driven by organic growth • Third quarter operating profit increased to $11.5 million, while adjusted operating profit increased 47.9% to $13.6 million • Third quarter diluted EPS in
How this was made
The 30-second read
Why it matters
The earnings beat and guidance reaffirmation provide a fresh data point for traders, supporting a short‑term bullish stance on TRS.
Market read
TRS earnings exceed prior period, reinforcing confidence in its turnaround after the aerospace divestiture.
What to watch
Potential headwinds from raw‑material cost volatility and temporary throughput challenges at Norris Cylinder.
TriMas reports third quarter net sales growth of 7.7%, adjusted operating profit growth of 47.9% and reaffirmed full-year adjusted diluted EPS outlook of $1.60 to $1.70.
Sales growth, adjusted operating-profit growth and adjusted EPS improved sharply, supported by cost actions and interest income, but Specialty Products profitability declined amid throughput issues and reported operating cash flow was negative.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net sales, three months ended September 30, 2026GAAP | $178.7M | – | 7.7% |
| Cost of sales, three months ended September 30, 2026GAAP | −$142.3M | – | – |
| Gross profit, three months ended September 30, 2026GAAP | $36.43M | – | – |
| Selling, general and administrative expenses, three months ended September 30, 2026GAAP | −$24.82M | – | – |
| Operating profit, three months ended September 30, 2026GAAP | $11.51M | – | – |
| Adjusted operating profit, three months ended September 30, 2026non-GAAP | $13.64M | – | 47.9% |
| Income from continuing operations, three months ended September 30, 2026GAAP | $13.46M | – | – |
| Adjusted income from continuing operations, three months ended September 30, 2026non-GAAP | $18.11M | – | – |
| Net income, three months ended September 30, 2026GAAP | $19.36M | – | – |
| Diluted earnings per share from continuing operations, three months ended September 30, 2026GAAP | $0.37 | – | – |
| Adjusted diluted EPS from continuing operations, three months ended September 30, 2026non-GAAP | $0.50 | – | 194.1% |
| Net income per diluted share, three months ended September 30, 2026GAAP | $0.53 | – | – |
| Net sales, nine months ended September 30, 2026GAAP | $521.6M | – | 6.4% |
| Operating profit, nine months ended September 30, 2026GAAP | $29.26M | – | – |
| Adjusted operating profit, nine months ended September 30, 2026non-GAAP | $41.23M | – | – |
| Income from continuing operations, nine months ended September 30, 2026GAAP | $28.97M | – | – |
| Net income, nine months ended September 30, 2026GAAP | $833.6M | – | – |
| Adjusted diluted EPS from continuing operations, nine months ended September 30, 2026non-GAAP | $1.25 | – | – |
| Net cash used in operating activities, three months ended September 30, 2026GAAP | −$66.73M | – | – |
| Free Cash Flow, three months ended September 30, 2026non-GAAP | $20.86M | – | – |
| Net cash used in operating activities, nine months ended September 30, 2026GAAP | −$124.6M | – | – |
| Capital expenditures, nine months ended September 30, 2026GAAP | −$20.16M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Packaging, three months ended September 30, 2026Growth across beauty and personal care, food and beverage, life sciences and industrial applications, as well as favorable foreign currency translation. | $147.6M | – | 8.8% |
| Specialty Products, three months ended September 30, 2026Higher sales volumes, partially offset in profitability by a lag in recovering increased raw material costs and temporary manufacturing inefficiencies. | $31.15M | – | 2.7% |
| Packaging, nine months ended September 30, 2026Organic sales growth was 3.4% and foreign exchange contributed 2.4%. | $429.7M | – | 5.8% |
| Specialty Products, nine months ended September 30, 2026Organic sales growth was 11.2%, partially offset by divestitures of (1.7)%. | $91.92M | – | 9.5% |
Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.
full-year 2026 outlook
- Revenue4% to 6% year-over-year sales growth across its combined Packaging and Specialty Products businesses
- NoteAdjusted diluted earnings per share of $1.60 to $1.70
- NoteApproximately 250 basis points of adjusted operating profit margin expansion year-over-year
- NoteApproximately $10 million of interest income during the fourth quarter of 2026
- NoteDiluted earnings per share (GAAP) of $1.06 to $1.13
Capital returns
- Repurchased 233,150 shares of outstanding common stock for $9.3 million during the third quarter of 2026.
- Repurchased 2,229,471 shares for $82.7 million year to date through September 30, 2026.
- Repurchases contributed to a 5.3% net reduction in shares outstanding compared to December 31, 2025.
- Approximately 35.6 million shares were outstanding as of September 30, 2026.
- $67.3 million remained under the share repurchase authorization as of September 30, 2026.
- Returned capital through a quarterly cash dividend of $0.04 per share.
- Since announcing the Aerospace divestiture in November 2025, repurchased more than 5.4 million shares.
What drove it
- Consolidated third-quarter sales growth was driven by organic growth within Packaging and Specialty Products and favorable foreign currency translation.
- Packaging adjusted operating profit and margin improved on cost-reduction actions, operational improvement initiatives and raw material cost recovery.
- Adjusted EPS benefited from interest income on cash and cash equivalents, cost-reduction initiatives and a lower share count from repurchases.
- The Company signed an agreement in October 2026 to sell Rapak, a provider of flexible bag-in-box packaging, dispensing and liquid filling solutions.
Concerns
- Specialty Products operating profit and margin declined year-over-year.
- Specialty Products faced a lag in recovering increased raw material costs, machine downtime and labor ramp-up.
- The Company cited continued temporary throughput challenges at Norris Cylinder.
- The outlook assumes no significant impact related to input costs or end market demand associated with global conflicts or geopolitical actions.
What to watch
- Closing of the Rapak sale, which is expected in November 2026.
- Progress in Specialty Products initiatives to improve throughput, machine and labor productivity, and cost efficiency.
- Realization of approximately $10 million of fourth-quarter interest income assumed in the outlook.
- Deployment of remaining TriMas Aerospace divestiture proceeds toward organic growth investments, strategic acquisitions and additional share repurchases.
- Delivery of approximately 250 basis points of adjusted operating profit margin expansion for full-year 2026.
Balance sheet and cash flow
- Cash and cash equivalents were $1,158,540 as of September 30, 2026, compared with $30,020 as of December 31, 2025.
- Long-term debt, net was $397,140 as of September 30, 2026, compared with $469,170 as of December 31, 2025.
- Net Debt was $(761,400) as of September 30, 2026, compared with $439,150 as of December 31, 2025.
- Cash and available borrowing capacity under the revolving credit facility was $1,372.8 million as of September 30, 2026.
- Net leverage ratio was 1.7x as defined in the Company's credit agreement.
- Net proceeds from disposition of business, property and equipment were $1,437,660 for the nine months ended September 30, 2026.
- Net cash used for financing activities was $(164,350) for the nine months ended September 30, 2026.
- The divestiture of TriMas Aerospace was completed on March 16, 2026, for approximately $1.5 billion in cash, generating net after-tax proceeds of approximately $1.2 billion.
Analysis
TriMas reported third-quarter net sales of $178,740, up 7.7% from $166,020. Packaging generated $147,590 of sales, up 8.8%, supported by growth across its major end markets and favorable foreign currency translation. Specialty Products generated $31,150, up 2.7%, as higher volumes supported sales. Consolidated organic growth was 7.2%, while foreign exchange contributed 0.5% to total growth.
Profitability improved materially at the consolidated level. GAAP operating profit was $11,510 versus an operating loss of $(3,180), while adjusted operating profit rose 47.9% to $13,640 from $9,220. The improvement reflected cost-reduction and organizational streamlining actions. GAAP income from continuing operations was $13,460, versus a loss of $(4,890), and adjusted diluted EPS from continuing operations rose to $0.50 from $0.17. The release attributes the adjusted EPS increase to interest income, cost initiatives and a lower share count from buybacks.
The segment picture remains uneven. Packaging adjusted operating profit was $20,360, compared with $18,190, reflecting cost actions, operational improvements and raw-material cost recovery. Specialty Products operating profit was $80, compared with $2,370, as increased volumes were more than offset by delayed raw-material cost recovery and manufacturing inefficiencies tied primarily to machine downtime and labor ramp-up. Management identified temporary throughput challenges at Norris Cylinder and is pursuing operational initiatives to improve productivity and cost efficiency.
The balance sheet changed substantially following the Aerospace divestiture. Cash and cash equivalents were $1,158,540 and Net Debt was $(761,400) as of September 30, 2026. The company used proceeds to repay revolving-credit borrowings, repurchase shares and satisfy transaction-related tax obligations, while retaining funds in liquid interest-bearing accounts. Third-quarter operating cash flow was $(66,730), but adjusted Free Cash Flow was $20,860. The company repurchased 233,150 shares for $9.3 million in the quarter and paid a quarterly dividend of $0.04 per share.
TriMas reaffirmed full-year adjusted diluted EPS guidance of $1.60 to $1.70 and raised expected combined Packaging and Specialty Products sales growth to 4% to 6% from its prior outlook of 3% to 6%. The outlook also calls for approximately 250 basis points of adjusted operating profit margin expansion and assumes approximately $10 million of fourth-quarter interest income. The guide includes announced acquisitions and divestitures as of October 29, 2026, including the planned sale of Rapak, which is expected to close in November 2026.
Management, verbatim
2026 has been a pivotal year for TriMas as we continue building a stronger, more focused company following the Aerospace divestiture.
Thomas Snyder, President and Chief Executive Officer
While our third quarter results have not yet fully reflected the benefits of these actions, and continued to be impacted by the temporary throughput challenges at Norris Cylinder, we are encouraged by the progress underway and the foundation we are building for improved performance over time.
Thomas Snyder, President and Chief Executive Officer
Not in the filing
stated, not guessed- Prior-quarter comparisons were not reported for the presented key metrics.
- GAAP and non-GAAP gross margin were not reported.
- GAAP operating-expense, gross-margin and tax-rate guidance were not reported.
- A prior earnings-release outlook document was not provided, so no actual-versus-prior-guidance comparison is presented.
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
TriMas Corp (NASDAQ:TRS) filed an 8‑K reporting its third‑quarter 2026 results, including a 7.7% sales increase and a reaffirmed full‑year EPS outlook.
Ticker impact
TriMas reported Q3 2026 net sales of $178.7M, operating profit $11.5M and reaffirmed FY EPS guidance of $1.60‑$1.70.
likely modest upside as investors price in stronger earnings and reaffirmed guidance
Quarterly earnings beat expectations and guidance reaffirmation typically support a short‑term price lift, especially given the cash‑rich balance sheet.
Market effects
Packaging and specialty products sector may see modest rally on stronger earnings trends.
U.S. small‑cap market could benefit from the earnings beat.
Limited to niche packaging industry; no broad macro impact.
Counterpoint
If the cost‑reduction benefits are already priced in, the reaffirmed guidance may not trigger further upside.
Key entities
- companyTriMas Corp
Packaging and specialty products manufacturer
